Skip to main content
SpringerLink
Log in

Epidemiology and Etiology

  • Chapter
  • First Online:
Myelodysplastic Syndromes

Part of the book series: Hematologic Malignancies ((HEMATOLOGIC))

  • 1266 Accesses

Abstract

Epidemiologic research of MDS has been fairly limited in comparison to other hematopoietic cancers (such as acute myeloid leukemia (AML)), no doubt due to difficulty in case-finding from a historical lack of reporting of MDS in cancer registries. MDS incidence has been recently reported in multiple studies since the International Classification of Diseases for Oncology, 3rd edition listed MDS as malignant, spurring its inclusion in cancer registries worldwide. The largest studies to date report rates (per 100,000 person-years) of 3.3 in the USA, 3.2 in Australia, and 1.8 in Europe. Nevertheless, these are likely underestimates based on evidence of incomplete reporting and underdiagnosis. Accepted causes of MDS are limited at this time to treatment-related chemotherapy and radiation and occupational exposure to benzene. Multiple case–control studies of potential lifestyle and environmental risk factors for MDS have been conducted, usually within the hospital setting. Probable causes, supported by multiple epidemiologic studies as well as similar findings for AML, are smoking, obesity, solvents and pesticides (without knowledge of specific exposures). Future research could contribute importantly with detailed (and preferably quantitative) assessment of specific exposures (e.g., specific types of pesticides), refined definition of homogeneous case groups by patterns of chromosomal abnormalities to identify etiologically relevant subgroups, and expanded investigation to include MDS cases previously missed because of incomplete reporting to registries or “underdiagnosis.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albin M, Bjork J, Welinder H et al (2003) Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures. Scand J Work Environ Health 29:378–387

    PubMed  Google Scholar 

  • Anderson LA, Pfeiffer RM, Landgren O et al (2009) Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100:822–828

    PubMed  CAS  Google Scholar 

  • Andrys C, Hanovcova I, Chylkova V et al (1997) Immunological monitoring of dry-cleaning shop workers–exposure to tetrachloroethylene. Cent Eur J Public Health 5:136–142

    PubMed  CAS  Google Scholar 

  • Awidi A, Magableh A, Taimeh Z et al (2009) Primary myelodysplastic syndrome in Jordan: a single-centre experience. Med Princ Pract 18:351–355

    PubMed  Google Scholar 

  • Baan R, Grosse Y, Straif K et al (2009) A review of human carcinogens – part F: chemical agents and related occupations. Lancet Oncol 10:1143–1144

    PubMed  Google Scholar 

  • Bauduer F, Ducout L, Dastugue N et al (1998) Epidemiology of myelodysplastic syndromes in a French general hospital of the Basque country. Leuk Res 22:205–208

    PubMed  CAS  Google Scholar 

  • Baumann Kreuziger LM, Steensma DP (2008) RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes. Am J Hematol 83: 822–823

    PubMed  Google Scholar 

  • Beane Freeman LE, Blair A, Lubin JH et al (2009) Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. J Natl Cancer Inst 101:751–761

    PubMed  CAS  Google Scholar 

  • Belli C, Acevedo S, Bengio R et al (2002) Detection of risk groups in myelodysplastic syndromes. A multicenter study. Haematologica 87:9–16

    PubMed  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT et al (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199

    PubMed  CAS  Google Scholar 

  • Bjork J, Johansson B, Broberg K et al (2009) Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case–control study. Leuk Res 33:788–791

    PubMed  Google Scholar 

  • Blair A, Freeman LB (2009) Epidemiologic studies in agricultural populations: observations and future directions. J Agromedicine 14:125–131

    PubMed  Google Scholar 

  • Blair A, Zheng T, Linos A et al (2001) Occupation and leukemia: a population-based case–control study in Iowa and Minnesota. Am J Ind Med 40:3–14

    PubMed  CAS  Google Scholar 

  • Bloomfield CD (1986) Chromosome abnormalities in secondary myelodysplastic syndromes. Scand J Haematol Suppl 45:82–90

    PubMed  CAS  Google Scholar 

  • Blossom SJ, Gilbert KM (2006) Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding. Toxicol Sci 92:103–114

    PubMed  CAS  Google Scholar 

  • Bolufer P, Collado M, Barragan E et al (2007) Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Br J Haematol 136:590–596

    PubMed  CAS  Google Scholar 

  • Bowles KM, Warner BA, Baglin TP (2006) Platelet mass has prognostic value in patients with myelodysplastic syndromes. Br J Haematol 135(2):198–200

    PubMed  Google Scholar 

  • Brown LM, Blair A, Gibson R et al (1990) Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res 50:6585–6591

    PubMed  CAS  Google Scholar 

  • Brown LM, Gibson R, Burmeister LF et al (1992) Alcohol consumption and risk of leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. Leuk Res 16:979–984

    PubMed  CAS  Google Scholar 

  • Cartwright RA, Gurney KA, Moorman AV (2002) Sex ratios and the risks of haematological malignancies. Br J Haematol 118:1071–1077

    PubMed  Google Scholar 

  • Catenacci DV, Schiller GJ (2005) Myelodysplastic syndromes: a comprehensive review. Blood Rev 19:301–319

    PubMed  CAS  Google Scholar 

  • Chen B, Zhao WL, Jin J et al (2005) Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 19:767–775

    PubMed  CAS  Google Scholar 

  • Cogle CR, Craig BM, Rollison DE et al (2011) Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. Blood 117:7121–7125

    PubMed  CAS  Google Scholar 

  • Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC (2006) Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. The National Academies Press, Washington, D.C

    Google Scholar 

  • Cowles SR, Bennett JM, Ross CE (1991) Medical surveillance for leukemia at a petrochemical manufacturing complex: four-year summary. J Occup Med 33:808–812

    PubMed  CAS  Google Scholar 

  • Dahabreh IJ, Giannouli S, Gota V et al (2010) GSTT1 and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Int J Cancer 126:1716–1723

    PubMed  CAS  Google Scholar 

  • Dalamaga M, Petridou E, Cook FE et al (2002) Risk factors for myelodysplastic syndromes: a case–control study in Greece. Cancer Causes Control 13:603–608

    PubMed  Google Scholar 

  • Dalamaga M, Nikolaidou A, Karmaniolas K et al (2007) Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case–control study. Oncology 73:26–32

    PubMed  Google Scholar 

  • Dalamaga M, Karmaniolas K, Papadavid E et al (2008) Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: a case–control study. Leuk Lymphoma 49:1545–1552

    PubMed  CAS  Google Scholar 

  • De Roos AJ, Deeg HJ, Davis S (2007) A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers. Cancer Causes Control 18:1199–1208

    PubMed  Google Scholar 

  • De Roos AJ, Deeg HJ, Onstad L et al (2010a) Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005–2006. Am J Hematol 85:765–770

    PubMed  Google Scholar 

  • De Roos AJ, Ulrich CM, Ray RM et al (2010b) Intentional weight loss and risk of lymphohematopoietic cancers. Cancer Causes Control 21:223–236

    PubMed  Google Scholar 

  • Du Y, Fryzek J, Sekeres MA et al (2010) Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res 34:1–5

    PubMed  CAS  Google Scholar 

  • Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489

    PubMed  CAS  Google Scholar 

  • Fabiani E, D’Alo F, Scardocci A et al (2009) Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 33:1068–1071

    PubMed  CAS  Google Scholar 

  • Farrow A, Jacobs A, West RR (1989) Myelodysplasia, chemical exposure, and other environmental factors. Leukemia 3:33–35

    PubMed  CAS  Google Scholar 

  • Finch SC (2004) Myelodysplasia and radiation. Radiat Res 161:603–606

    PubMed  CAS  Google Scholar 

  • Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva, Ref Type: Report

    Google Scholar 

  • Germing U, Strupp C, Kundgen A et al (2004) No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 89:905–910

    PubMed  Google Scholar 

  • Germing U, Aul C, Niemeyer CM et al (2008) Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 87:691–699

    PubMed  Google Scholar 

  • Goldberg H, Lusk E, Moore J et al (1990) Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease. Cancer Res 50:6876–6881

    PubMed  CAS  Google Scholar 

  • Golding BT, Watson WP (1999) Possible mechanisms of carcinogenesis after exposure to benzene. IARC Sci Publ (150):75–88

    Google Scholar 

  • Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088

    PubMed  CAS  Google Scholar 

  • Griffin JM, Gilbert KM, Lamps LW et al (2000) CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci 57:345–352

    PubMed  CAS  Google Scholar 

  • Guralnik JM, Eisenstaedt RS, Ferrucci L et al (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104:2263–2268

    PubMed  CAS  Google Scholar 

  • Gyuali Z, Balog A, Borbenyi Z et al (2005) Genetic polymorphisms in patients with myelodysplastic syndrome. Acta Microbiol Immunol Hung 52(3-4):463–475

    PubMed  CAS  Google Scholar 

  • Hauptmann M, Lubin JH, Stewart PA et al (2003) Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst 95:1615–1623

    PubMed  CAS  Google Scholar 

  • Haus O, Kotlarek-Haus S, Potoczek S et al (2006) Myelodysplastic syndromes according to FAB and WHO classification. Single center experience. Neoplasma 53:136–143

    PubMed  CAS  Google Scholar 

  • Hayes RB, Yin SN, Dosemeci M et al (1997) Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine – National Cancer Institute Benzene Study Group. J Natl Cancer Inst 89:1065–1071 (see comments)

    PubMed  CAS  Google Scholar 

  • Honda Y, Delzell E, Cole P (1995) An updated study of mortality among workers at a petroleum manufacturing plant. J Occup Environ Med 37:194–200

    PubMed  CAS  Google Scholar 

  • Howe GR, Lindsay JP (1983) A follow-up study of a ten-percent sample of the Canadian labor force. I. Cancer mortality in males, 1965–73. J Natl Cancer Inst 70:37–44

    PubMed  CAS  Google Scholar 

  • Ido M, Nagata C, Kawakami N et al (1996) A case–control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20:727–731

    PubMed  CAS  Google Scholar 

  • Irons RD, Gross SA, Le A et al (2010) Integrating WHO 2001–2008 criteria for the diagnosis of myelodysplastic syndrome (MDS): a case-case analysis of benzene exposure. Chem Biol Interact 184:30–38

    PubMed  CAS  Google Scholar 

  • Irwin J, D’Souza A, Johnson L et al (2011) Myelodysplasia in the Wellington region 2002–2007: disease incidence and treatment patterns. Intern Med J 41:399–407

    PubMed  CAS  Google Scholar 

  • Jaffe ES (2001) Pathology & genetics, tumours of haematopoietic and lymphoid tissues, World Health Organization classification of tumours. IARC Press, Lyon

    Google Scholar 

  • Keller-Byrne JE, Khuder SA, Schaub EA (1995) Meta-analysis of leukemia and farming. Environ Res 71:1–10

    PubMed  CAS  Google Scholar 

  • Khalade A, Jaakkola MS, Pukkala E et al (2010) Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ Health 9:31

    PubMed  Google Scholar 

  • Kokouva M, Bitsolas N, Hadjigeorgiou GM et al (2011) Pesticide exposure and lymphohaematopoietic cancers: a case–control study in an agricultural region (Larissa, Thessaly, Greece). BMC Public Health 11:5

    PubMed  Google Scholar 

  • Kristinsson SY, Bjorkholm M, Hultcrantz M et al (2011) Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 29:2897–2903

    PubMed  Google Scholar 

  • Kuendgen A, Matsuda A, Germing U (2007) Differences in epidemiology of MDS between Western and Eastern countries: ethnic differences or environmental influence? Leuk Res 31:103–104

    PubMed  Google Scholar 

  • Leone G, Fianchi L, Pagano L et al (2010) Incidence and susceptibility to therapy-related myeloid neoplasms. Chem Biol Interact 184:39–45

    PubMed  CAS  Google Scholar 

  • Levine EG, Bloomfield CD (1992) Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:47–84

    PubMed  CAS  Google Scholar 

  • Lichtman MA (2010) Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist 15:1083–1101

    PubMed  Google Scholar 

  • Lv L, Lin GW, Wang XQ et al (2007) A case–control study of risk factors for myelodysplastic syndromes. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 25:705–709

    PubMed  Google Scholar 

  • Lv L, Lin G, Gao X et al (2011) Case–control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population. Am J Hematol 86:163–169

    PubMed  Google Scholar 

  • Ma X, Does M, Raza A et al (2007) Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109:1536–1542

    PubMed  Google Scholar 

  • Ma X, Lim U, Park Y et al (2009) Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol 169:1492–1499

    PubMed  Google Scholar 

  • Ma W, Kantarjian H, Zhang K et al (2010) Significant association between polymorphism of the ­erythropoietin gene promoter and myelodysplastic syndrome. BMC Med Genet 11:163

    PubMed  CAS  Google Scholar 

  • Ma X, Wang R, Galili N et al (2011) Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes. Cancer Causes Control 22:623–629

    PubMed  Google Scholar 

  • Maciejewski JP, Tiu RV, O’Keefe C (2009) Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol 146:479–488

    PubMed  CAS  Google Scholar 

  • MacInnis RJ, English DR, Hopper JL et al (2005) Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 97:1154–1157

    PubMed  Google Scholar 

  • Maynadie M, Girodon F, Manivet-Janoray I et al (2011) Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d’Or (Burgundy, France). Haematologica 96:55–61

    PubMed  Google Scholar 

  • McHale CM, Lan Q, Corso C et al (2008) Chromosome translocations in workers exposed to benzene. J Natl Cancer Inst Monogr (39):74–77

    Google Scholar 

  • McNally RJ, Rowland D, Roman E et al (1997) Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol 15:173–189

    PubMed  CAS  Google Scholar 

  • Mele A, Szklo M, Visani G et al (1994) Hair dye use and other risk factors for leukemia and pre-leukemia: a case–control study. Italian Leukemia Study Group. Am J Epidemiol 139:609–619

    PubMed  CAS  Google Scholar 

  • Moorman AV, Roman E, Cartwright RA et al (2002) Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups. Br J Cancer 86:60–62

    PubMed  CAS  Google Scholar 

  • Motohashi N, Nagashima H, Molnar J (1999) Trichloroethylene. II. Mechanism of carcinogenicity of trichloroethylene. In Vivo 13:215–219

    PubMed  CAS  Google Scholar 

  • Mukiibi JM, Paul B (1994) Myelodysplastic syndromes (MDS) in Central Africans. Trop Geogr Med 46:17–19

    PubMed  CAS  Google Scholar 

  • Nagata C, Shimizu H, Hirashima K et al (1999) Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 23:57–62

    PubMed  CAS  Google Scholar 

  • Neukirchen J, Schoonen WM, Strupp C et al (2011) Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry. Leuk Res 35:1591–1596

    PubMed  Google Scholar 

  • Nisse C, Haguenoer JM, Grandbastien B et al (2001) Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112:927–935

    PubMed  CAS  Google Scholar 

  • Pekmezovic T, Suvajdzic VN, Kisic D et al (2006) A case–control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro). Ann Hematol 85:514–519

    PubMed  Google Scholar 

  • Phekoo KJ, Richards MA, Moller H et al (2006) The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica 91:1400–1404

    PubMed  Google Scholar 

  • Powers MP, Nishino H, Luo Y et al (2007) Polymorphisms in TGFbeta and TNFalpha are associated with the myelodysplastic syndrome phenotype. Arch Pathol Lab Med 131(12):1789–1793

    PubMed  Google Scholar 

  • Preston DL, Kusumi S, Tomonaga M et al (1994) Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res 137:S68–S97

    PubMed  CAS  Google Scholar 

  • Radlund A, Thiede T, Hansen S et al (1995) Incidence of myelodysplastic syndromes in a Swedish population. Eur J Haematol 54:153–156

    PubMed  CAS  Google Scholar 

  • Richardson D, Sugiyama H, Nishi N et al (2009) Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950–2000. Radiat Res 172:368–382

    PubMed  CAS  Google Scholar 

  • Rigolin GM, Cuneo A, Roberti MG et al (1998) Exposure to myelotoxic agents and myelodysplasia: case–control study and correlation with clinicobiological findings. Br J Haematol 103:189–197

    PubMed  CAS  Google Scholar 

  • Rodger EJ, Morison IM (2011) Myelodysplastic syndrome in New Zealand and Australia. Intern Med J 42(11):1235–1242

    Google Scholar 

  • Rollison DE, Howlader N, Smith MT et al (2008) Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood 112:45–52

    PubMed  CAS  Google Scholar 

  • Ross JA, Parker E, Blair CK et al (2004) Body mass index and risk of leukemia in older women. Cancer Epidemiol Biomarkers Prev 13:1810–1813

    PubMed  Google Scholar 

  • Rubin CM, Larson RA, Anastasi J et al (1990) t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594–2598

    PubMed  CAS  Google Scholar 

  • Sandler DP, Shore DL, Anderson JR et al (1993) Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst 85:1994–2003

    PubMed  CAS  Google Scholar 

  • Sant M, Allemani C, Tereanu C et al (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734

    PubMed  CAS  Google Scholar 

  • Sekeres MA (2011) Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010. J Natl Compr Canc Netw 9:57–63

    PubMed  Google Scholar 

  • Sekeres MA, Schoonen WM, Kantarjian H et al (2008) Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst 100:1542–1551

    PubMed  Google Scholar 

  • Shimizu H, Matsushita Y, Aoki K et al (1995) Prevalence of the myelodysplastic syndromes in Japan. Int J Hematol 61:17–22

    PubMed  CAS  Google Scholar 

  • Singh ZN, Huo D, Anastasi J et al (2007) Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol 127:197–205

    PubMed  Google Scholar 

  • Steensma DP, Bennett JM (2006) The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc 81:104–130

    PubMed  Google Scholar 

  • Strom SS, Gu Y, Gruschkus SK et al (2005) Risk factors of myelodysplastic syndromes: a case–control study. Leukemia 19:1912–1918

    PubMed  CAS  Google Scholar 

  • Surveillance, Epidemiology, and End Results (SEER) Program (2011) www.seer.cancer.gov. SEER*Stat Database: Incidence – SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2010 Sub (2000–2008) < Katrina/Rita Population Adjustment > − Linked To County Attributes – Total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011 (updated 10/28/2011), based on the November 2010 submission. Ref Type: Report

  • Tao L, Li Y, Kramer PM et al (2004) Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Toxicology 196:127–136

    PubMed  CAS  Google Scholar 

  • Tettamanti M, Lucca U, Gandini F et al (2010) Prevalence, incidence and types of mild anemia in the elderly: the “Health and Anemia” population-based study. Haematologica 95:1849–1856

    PubMed  Google Scholar 

  • Tiu RV, Gondek LP, O’Keefe CL et al (2011) Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood 117:4552–4560

    PubMed  CAS  Google Scholar 

  • Van Maele-Fabry GV, Duhayon S, Lison D (2007) A systematic review of myeloid leukemias and occupational pesticide exposure. Cancer Causes Control 18:457–478

    PubMed  Google Scholar 

  • Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937–951

    PubMed  CAS  Google Scholar 

  • West RR, Stafford DA, Farrow A et al (1995) Occupational and environmental exposures and myelodysplasia: a case–control study. Leuk Res 19:127–139

    PubMed  CAS  Google Scholar 

  • Williamson PJ, Kruger AR, Reynolds PJ et al (1994) Establishing the incidence of myelodysplastic syndrome. Br J Haematol 87:743–745

    PubMed  CAS  Google Scholar 

  • Zhang L, Rothman N, Li G et al (2007) Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ Mol Mutagen 48:467–474

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Environmental and Occupational Health, Drexel University School of Public Health, 1505 Race St., Philadelphia, PA, 19102, USA

    Anneclaire J. De Roos

Authors
  1. Anneclaire J. De Roos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anneclaire J. De Roos .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

De Roos, A.J. (2013). Epidemiology and Etiology. In: Myelodysplastic Syndromes. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36229-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-36229-3_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-36228-6

  • Online ISBN: 978-3-642-36229-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation